36427589|t|Hyperactivation of TRPV4 causes the hippocampal pyroptosis pathway and results in cognitive impairment in LPS-treated mice.
36427589|a|Pyroptosis, a newly discovered proinflammatory programmed cell death, is involved in the regulation of cognitive dysfunction, such as Alzheimer's disease. Exploring potential drug targets that prevent pyroptotic procedures might benefit the development of a cure for these diseases. In the present study, we explored whether the transient receptor potential vanilloid 4 (TRPV4) blocker HC067047 and knockdown of TRPV4 in the hippocampus could improve cognitive behavior through the inhibition of pyroptosis in a mouse model developed using systemic administration of lipopolysaccharide (LPS). We found that systemic administration of HC067047 or knockdown of hippocampal TRPV4 prevented the activation of canonical and noncanonical pyroptosis in the hippocampus of LPS-treated mice. Consistent with the inhibition of the hippocampal pyroptosis pathway, a knockdown of hippocampal TRPV4 lowered expression of TNF-alpha, IL-1beta, IL-18, and IL-6. Furthermore, we verified that the main pyroptosis cell type might be a neuron, indicated by reduced neuronal marker expression. Mechanically, we also found that knockdown of hippocampal TRPV4 might inhibit phosphorylation of CamkIIalpha which results in NFkappab mediated inflammasome reduction in the hippocampus of LPS-treated mice. More interestingly, mice intraperitoneally injected with HC067047 or the hippocampus injected with TRPV4 shRNA showed improved cognitive behavior, as indicated by the enhanced discrimination ratio in the NORT, NOPT, and SNPT. Collectively, we consider that HC067047 might be a small molecular drug that prevents pyroptosis, and TRPV4 could be an effective therapeutic target for preventing pyroptosis-induced cognitive dysfunction.
36427589	19	24	TRPV4	Gene	63873
36427589	48	58	pyroptosis	Disease	
36427589	82	102	cognitive impairment	Disease	MESH:D003072
36427589	106	109	LPS	Chemical	MESH:D008070
36427589	118	122	mice	Species	10090
36427589	124	134	Pyroptosis	Disease	
36427589	155	170	proinflammatory	Disease	
36427589	227	248	cognitive dysfunction	Disease	MESH:D003072
36427589	258	277	Alzheimer's disease	Disease	MESH:D000544
36427589	453	493	transient receptor potential vanilloid 4	Gene	63873
36427589	495	500	TRPV4	Gene	63873
36427589	510	518	HC067047	Chemical	MESH:C000723128
36427589	536	541	TRPV4	Gene	63873
36427589	620	630	pyroptosis	Disease	
36427589	636	641	mouse	Species	10090
36427589	691	709	lipopolysaccharide	Chemical	MESH:D008070
36427589	711	714	LPS	Chemical	MESH:D008070
36427589	758	766	HC067047	Chemical	MESH:C000723128
36427589	795	800	TRPV4	Gene	63873
36427589	856	866	pyroptosis	Disease	
36427589	889	892	LPS	Chemical	MESH:D008070
36427589	901	905	mice	Species	10090
36427589	957	967	pyroptosis	Disease	
36427589	1004	1009	TRPV4	Gene	63873
36427589	1032	1041	TNF-alpha	Gene	21926
36427589	1043	1051	IL-1beta	Gene	16176
36427589	1053	1058	IL-18	Gene	16173
36427589	1064	1068	IL-6	Gene	16193
36427589	1109	1119	pyroptosis	Disease	
36427589	1256	1261	TRPV4	Gene	63873
36427589	1324	1332	NFkappab	Gene	18033
36427589	1387	1390	LPS	Chemical	MESH:D008070
36427589	1399	1403	mice	Species	10090
36427589	1425	1429	mice	Species	10090
36427589	1462	1470	HC067047	Chemical	MESH:C000723128
36427589	1504	1509	TRPV4	Gene	63873
36427589	1662	1670	HC067047	Chemical	MESH:C000723128
36427589	1717	1727	pyroptosis	Disease	
36427589	1733	1738	TRPV4	Gene	63873
36427589	1795	1805	pyroptosis	Disease	
36427589	1814	1835	cognitive dysfunction	Disease	MESH:D003072
36427589	Positive_Correlation	MESH:D008070	MESH:D003072
36427589	Positive_Correlation	16176	63873
36427589	Association	18033	63873
36427589	Positive_Correlation	16193	63873
36427589	Association	MESH:D008070	63873
36427589	Negative_Correlation	MESH:C000723128	63873
36427589	Association	MESH:D003072	63873
36427589	Positive_Correlation	21926	63873
36427589	Positive_Correlation	16173	63873

